Patients with Alzheimer’s disease, multiple sclerosis, amyotrophic lateral sclerosis, stroke, spinal cord injury, or epilepsy are known to have increased MMP-9 and MMP-2 levels in the central nervous system [47,48,49,50,51]. Here, MMP2 is linked to amyotrophic lateral sclerosis.